GlassScriptPhysician profile
Thomas Beau Cawley
NPI 1568866010
$8,453.28
in general payments reported to CMS, 2019-2025
60 companies · $2,032 in 2025
The $2,032 reported for 2025 was more than what 91% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,389 · 2022: $1,306 · 2023: $1,561 · 2024: $2,166 · 2025: $2,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,758.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,767.49 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $870.80 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $621.77 | 2021-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $586.47 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $569.87 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $348.46 | 2022-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $345.15 | 2021-2025 | Trintellix |
| Abbott Laboratories | $337.82 | 2021-2025 | Freestyle Libre 3 |
| Pfizer INC. | $301.57 | 2023-2025 | |
| Glaxosmithkline, LLC. | $220.11 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Phathom Pharmaceuticals, INC. | $168.88 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $168.63 | 2021-2025 | |
| Dexcom, INC. | $142.98 | 2023-2025 | Dexcom G6 Transmitter |
| Corium, LLC | $136.69 | 2022-2024 | Azstarys, Adlarity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.52 | 2021-2025 | Jardiance |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $134.00 | 2022 | |
| Lundbeck LLC | $129.38 | 2023-2025 | Rexulti, Vyepti |
| Esperion Therapeutics, INC. | $125.43 | 2021-2024 | Nexletol |
| Eisai INC. | $88.63 | 2024-2025 | |
| Ardelyx, INC. | $85.19 | 2024-2025 | Ibsrela |
| Biohaven Pharmaceuticals, INC. | $81.88 | 2021 | |
| Axsome Therapeutics, INC. | $68.91 | 2025 | Symbravo, Sunosi |
| Sumitomo Pharma America, INC. | $64.53 | 2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.89 | 2022-2025 | Caplyta |
| Radius Health, INC. | $49.86 | 2025 | Tymlos |
| Dynavax Technologies Corporation | $47.64 | 2023-2024 | Heplisav-B |
| Merck Sharp & Dohme LLC | $42.20 | 2021-2025 | Gardasil 9, Capvaxive |
| Antares Pharma, INC. | $42.04 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Paratek Pharmaceuticals, INC. | $40.87 | 2021 | |
| Almatica Pharma LLC | $39.47 | 2021-2022 | |
| Exact Sciences Corporation | $39.34 | 2024-2025 | Cologuard Collection Kit |
| Kaleo, INC. | $34.62 | 2021-2023 | Auvi-Q |
| Edwards Lifesciences Corporation | $31.08 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astellas Pharma US INC | $28.64 | 2021-2024 | Veozah |
| Teva Pharmaceuticals USA, INC. | $26.29 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $25.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $24.81 | 2022-2023 | Eliquis |
| Amarin Pharma, INC. | $24.40 | 2022 | |
| Insulet Corporation | $24.21 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $22.95 | 2025 | Neffy |
| Endo Pharmaceuticals INC. | $22.56 | 2024 | Xiaflex, Aveed |
| Gilead Sciences, INC. | $20.23 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $19.89 | 2024 | Rexulti |
| Atricure, INC. | $19.32 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Genentech USA, INC. | $18.35 | 2021 | |
| Philips North America LLC | $18.18 | 2024 | (Ck6) Holter |
| Viatris Specialty LLC | $17.47 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $17.25 | 2023 | Inspire |
| Sandoz INC. | $16.85 | 2025 | Hyrimoz |
| Sanofi-Aventis U.S. LLC | $16.82 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.64 | 2022 | |
| Abiomed | $16.44 | 2024 | Impella |
| Lifescan, INC. | $15.75 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.23 | 2024 | Quviviq |
| Medtronic, INC. | $15.07 | 2025 | Closurerfs |
| Xeris Pharmaceuticals, INC. | $14.82 | 2025 | Gvoke Hypopen |
| Seqirus USA INC | $14.61 | 2022 | |
| Tolmar, INC. | $14.32 | 2023 | |
| Currax Pharmaceuticals LLC | $13.95 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Cawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.